Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Resisting bacterial drug resistance.

John S Blanchard1

  • 1Department of Biochemistry, Albert Einstein College of Medicine of Yeshiva University, Jack and Pearl Resnick Campus, 1300 Morris Park Avenue, Bronx, NY 10461, USA.

Chemistry & Biology
|March 6, 2003
PubMed
Summary

Researchers developed a novel method using cationic peptides to inhibit bacterial enzymes that cause drug resistance. This dual-action approach combats antibiotic resistance, making bacterial defense more challenging.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The active site of the <i>Mycobacterium tuberculosis</i> branched-chain amino acid biosynthesis enzyme dihydroxyacid dehydratase contains a 2Fe-2S cluster.

The Journal of biological chemistry·2019
Same author

Biochemical Characterization of the Mycobacterium smegmatis Threonine Deaminase.

Biochemistry·2018
Same author

Bacterial Branched-Chain Amino Acid Biosynthesis: Structures, Mechanisms, and Drugability.

Biochemistry·2017
Same author

Mechanistic Characterization of Escherichia coli l-Aspartate Oxidase from Kinetic Isotope Effects.

Biochemistry·2017
Same author

Mechanism-Based Inhibition of the Mycobacterium tuberculosis Branched-Chain Aminotransferase by d- and l-Cycloserine.

ACS chemical biology·2017
Same author

Identification of Mycobacterial RplJ/L10 and RpsA/S1 Proteins as Novel Targets for CD4<sup>+</sup> T Cells.

Infection and immunity·2017

Area of Science:

  • Biochemistry
  • Microbiology
  • Drug Discovery

Background:

  • Antibiotic resistance is a growing global health threat.
  • Enzymes that confer drug resistance in bacteria are key targets for new therapies.
  • Developing strategies to overcome bacterial defense mechanisms is crucial.

Purpose of the Study:

  • To present an innovative method for inhibiting bacterial drug resistance enzymes.
  • To explore the potential of cationic peptides as antibacterial agents.
  • To develop a dual-action strategy against microbial resistance.

Main Methods:

  • Utilized cationic peptides as enzyme inhibitors.
  • Investigated the inhibition of enzymes critical for bacterial drug resistance.
  • Assessed the dual antibacterial mechanisms employed by the peptides.

Main Results:

  • Demonstrated an elegant method for inhibiting key bacterial resistance enzymes.
  • Successfully employed cationic peptides to target these enzymes.
  • Showcased a dual-action antibacterial strategy that hinders microbial retaliation.

Conclusions:

  • Cationic peptides offer a promising approach to combat antibiotic resistance.
  • The dual-action mechanism significantly challenges bacterial defense.
  • This strategy represents a significant advancement in developing new antibacterial treatments.

Related Experiment Videos